AU2001251655A1 - Cytokine uses; compositions; methods - Google Patents

Cytokine uses; compositions; methods

Info

Publication number: AU2001251655A1
Authority: AU; Australia
Prior art keywords: methods; compositions; cytokine; cytokine uses; facts
Prior art date: 2000-04-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001251655A

Other languages

English (en)

Inventor

Stephen D. Hurst

Donna M. Rennick

Sandra M. Zurawski

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Sharp and Dohme LLC

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2001-04-17

Publication date

2001-10-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22733587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001251655(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-17 Application filed by Schering Corp filed Critical Schering Corp

2001-10-30 Publication of AU2001251655A1 publication Critical patent/AU2001251655A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Virology (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
Gastroenterology & Hepatology (AREA)
Mycology (AREA)
Obesity (AREA)
Zoology (AREA)
Rheumatology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Physical Education & Sports Medicine (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)

AU2001251655A 2000-04-18 2001-04-17 Cytokine uses; compositions; methods Abandoned AU2001251655A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US19848800P	2000-04-18	2000-04-18
US60198488		2000-04-18
PCT/US2001/012493 WO2001079288A2 (fr)	2000-04-18	2001-04-17	Utilisations de cytokine; compositions; et methodes

Publications (1)

Publication Number	Publication Date
AU2001251655A1 true AU2001251655A1 (en)	2001-10-30

Family

ID=22733587

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001251655A Abandoned AU2001251655A1 (en)	2000-04-18	2001-04-17	Cytokine uses; compositions; methods

Country Status (14)

Country	Link
US (6)	US6676939B2 (fr)
EP (3)	EP2389943A1 (fr)
JP (2)	JP2004501088A (fr)
AT (1)	ATE416782T1 (fr)
AU (1)	AU2001251655A1 (fr)
CA (1)	CA2406245A1 (fr)
CY (1)	CY1108835T1 (fr)
DE (1)	DE60136921D1 (fr)
DK (1)	DK1274450T3 (fr)
ES (1)	ES2317898T3 (fr)
MX (1)	MXPA02010275A (fr)
PT (1)	PT1274450E (fr)
SI (1)	SI1274450T1 (fr)
WO (1)	WO2001079288A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2290081A3 (fr) *	1999-12-23	2012-08-01	Genentech, Inc.	Polypeptides allogéniques IL-17 et utilisations thérapeutiques
AU2001251655A1 (en) *	2000-04-18	2001-10-30	Schering Corporation	Cytokine uses; compositions; methods
US20020037524A1 (en) *	2000-06-22	2002-03-28	Eugene Medlock	IL-17 like molecules and uses thereof
US20030124092A1 (en) *	2001-06-21	2003-07-03	Eugene Medlock	IL-17 like molecules and uses thereoflike molecules and uses thereof
AU2005307831A1 (en) *	2004-11-17	2006-05-26	Amgen, Inc.	Fully human monoclonal antibodies to IL-13
US8454955B2 (en) *	2007-11-28	2013-06-04	Riken	Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia
AU2009245440C1 (en)	2008-05-05	2013-03-14	Novimmune Sa	Anti-IL-17A/IL-17F cross-reactive antibodies and methods of use thereof
AU2010244142B2 (en)	2009-05-05	2016-07-21	Novimmune Sa	Anti-IL-17F antibodies and methods of use thereof
RS56904B1 (sr) *	2010-03-30	2018-05-31	Janssen Biotech Inc	Humanizovna il-25 antitela
US8956859B1 (en)	2010-08-13	2015-02-17	Aviex Technologies Llc	Compositions and methods for determining successful immunization by one or more vaccines

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US676939A (en) *	1899-11-21	1901-06-25	Samuel S Eveland	Antifriction end-thrust device.
NL154598B (nl)	1970-11-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en)	1971-05-14	1974-06-18	Syva Corp	Enzyme amplification assay
US3939350A (en)	1974-04-29	1976-02-17	Board Of Trustees Of The Leland Stanford Junior University	Fluorescent immunoassay employing total reflection for activation
US3996345A (en)	1974-08-12	1976-12-07	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en)	1978-04-05	1981-07-07	Syva Company	Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en)	1978-11-24	1981-06-23	Syva Company	Macromolecular environment control in specific receptor assays
US4391904A (en)	1979-12-26	1983-07-05	Syva Company	Test strip kits in immunoassays and compositions therein
US4366241A (en)	1980-08-07	1982-12-28	Syva Company	Concentrating zone method in heterogeneous immunoassays
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4732863A (en)	1984-12-31	1988-03-22	University Of New Mexico	PEG-modified antibody with reduced affinity for cell surface Fc receptors
DE69634726T2 (de) *	1995-07-19	2006-05-04	Genetics Institute, LLC, Cambridge	Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
US6569645B2 (en) *	1999-05-14	2003-05-27	Genentech, Inc.	IL-17 homologous polypeptides and therapeutic uses thereof
WO1999014240A1 (fr) *	1997-09-17	1999-03-25	Human Genome Sciences, Inc.	Proteine de type recepteur d'interleukine 17
US6562578B1 (en) *	1999-01-11	2003-05-13	Schering Corporation	IL-17-like cytokine binding compounds and antibodies
IL138930A0 (en)	1998-05-15	2001-11-25	Genentech Inc	Il-17 homologies polypeptides and therapeutic uses thereof
AU4208799A (en)	1998-05-29	1999-12-13	Human Genome Sciences, Inc.	Interleukins-21 and 22
WO2000020593A1 (fr) *	1998-10-02	2000-04-13	Eli Lilly And Company	Acides nucleiques, polypeptides, vecteurs, cellules hotes homologues de l'il-17, leurs procedes de production et leurs utilisations
CA2361204A1 (fr) *	1999-01-11	2000-07-20	Schering Corporation	Cytokines de mammiferes liees a l'interleukin-17, polynucleotides les codant et leurs utilisations
ATE541931T1 (de) *	1999-12-23	2012-02-15	Genentech Inc	Il-17-homologe polypeptide und ihre therapeutische verwendung
AU2001251655A1 (en) *	2000-04-18	2001-10-30	Schering Corporation	Cytokine uses; compositions; methods
WO2004013281A2 (fr) *	2002-08-05	2004-02-12	Eli Lilly And Company	Nouvelles proteines et leurs utilisations

2001
- 2001-04-17 AU AU2001251655A patent/AU2001251655A1/en not_active Abandoned
- 2001-04-17 EP EP10011811A patent/EP2389943A1/fr not_active Withdrawn
- 2001-04-17 MX MXPA02010275A patent/MXPA02010275A/es active IP Right Grant
- 2001-04-17 US US09/836,385 patent/US6676939B2/en not_active Expired - Fee Related
- 2001-04-17 DE DE60136921T patent/DE60136921D1/de not_active Expired - Lifetime
- 2001-04-17 DK DK01925057T patent/DK1274450T3/da active
- 2001-04-17 CA CA002406245A patent/CA2406245A1/fr not_active Abandoned
- 2001-04-17 AT AT01925057T patent/ATE416782T1/de active
- 2001-04-17 EP EP01925057A patent/EP1274450B1/fr not_active Revoked
- 2001-04-17 SI SI200130904T patent/SI1274450T1/sl unknown
- 2001-04-17 EP EP08017308A patent/EP2020239A1/fr not_active Withdrawn
- 2001-04-17 JP JP2001576883A patent/JP2004501088A/ja active Pending
- 2001-04-17 ES ES01925057T patent/ES2317898T3/es not_active Expired - Lifetime
- 2001-04-17 WO PCT/US2001/012493 patent/WO2001079288A2/fr not_active Ceased
- 2001-04-17 PT PT01925057T patent/PT1274450E/pt unknown
2003
- 2003-11-10 US US10/705,183 patent/US7357924B2/en not_active Expired - Fee Related
2007
- 2007-12-17 US US11/957,994 patent/US20090263401A1/en not_active Abandoned
2009
- 2009-03-03 CY CY20091100242T patent/CY1108835T1/el unknown
- 2009-11-06 US US12/614,003 patent/US20100136020A1/en not_active Abandoned
2011
- 2011-04-20 US US13/090,483 patent/US20110223130A1/en not_active Abandoned
- 2011-08-05 JP JP2011172391A patent/JP2011219501A/ja active Pending
2012
- 2012-01-25 US US13/357,962 patent/US20120141411A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2020239A1 (fr)	2009-02-04
MXPA02010275A (es)	2003-04-25
WO2001079288A2 (fr)	2001-10-25
WO2001079288A3 (fr)	2002-05-10
US7357924B2 (en)	2008-04-15
ATE416782T1 (de)	2008-12-15
EP1274450B1 (fr)	2008-12-10
US20040076608A1 (en)	2004-04-22
EP2389943A1 (fr)	2011-11-30
ES2317898T3 (es)	2009-05-01
JP2004501088A (ja)	2004-01-15
US20090263401A1 (en)	2009-10-22
SI1274450T1 (sl)	2009-04-30
US20100136020A1 (en)	2010-06-03
JP2011219501A (ja)	2011-11-04
US20110223130A1 (en)	2011-09-15
US20120141411A1 (en)	2012-06-07
EP1274450A2 (fr)	2003-01-15
DK1274450T3 (da)	2009-04-06
PT1274450E (pt)	2009-03-06
US20030165460A1 (en)	2003-09-04
CA2406245A1 (fr)	2001-10-25
DE60136921D1 (de)	2009-01-22
CY1108835T1 (el)	2014-07-02
US6676939B2 (en)	2004-01-13

Publication	Publication Date	Title
MY135233A (en)	2008-03-31	N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
DE69716135D1 (en)	2002-11-07	In 6-position durch thio substituierte paclitaxele
TR200202194T2 (tr)	2003-01-21	Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
ZA200205557B (en)	2003-07-11	4-Aminopicolinates and their use as herbicides.
MXPA02006402A (es)	2003-09-22	Resina de poliolefian modificada, composicion de resina de poliolefina modificada y usos de las mismas.
WO2003029420A3 (fr)	2004-11-04	Variants de ligands apo-2 et leurs utilisations
CY1108835T1 (el)	2014-07-02	Θεραπευτικες χρησεις αγωνιστων και ανταγωνιστων της il174
WO2002102586A3 (fr)	2003-03-20	Composites cellulose et polymere et procede de fabrication
MXPA03001497A (es)	2004-05-04	Metodos para formar composiciones dentifricas, y sus productos.
MXPA03004932A (es)	2003-09-10	2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
CA95794S (en)	2003-02-03	Paving stone
ES2180319T3 (es)	2003-02-01	Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
MXPA03008896A (es)	2003-12-08	Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos.
AU2002361337A1 (en)	2003-07-09	Amphoteric polysaccharide, composition and use
PT929299E (pt)	2004-02-27	1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b\| benzofuranos substituidos
MX2007007355A (es)	2007-07-09	5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
WO2003048106A3 (fr)	2004-03-25	1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
ES2184608A1 (es)	2003-04-01	Fertilizantes organicos-minerales complejos.
AU2001234687A1 (en)	2001-08-14	Fused -al2o3-mgo-y2o3 eutectic abrasive particles, abrasive articles, and methods of making and using the same
AU2003211651A1 (en)	2003-11-03	5,6-DIPHENYLIMIDAZO(1,2-a)PYRIMIDINE AND BACTERICIDAL COMPOSITION CONTAINING THE SAME
WO2003037251A3 (fr)	2004-03-04	Activation des bob/gpr15 induite par hivgp120
AU2002332244A1 (en)	2004-04-19	Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions
AU2001266606A1 (en)	2001-12-03	Compositions with anti-proliferative activities and methods for use thereof
AU2001294910A1 (en)	2002-04-15	3-thioxo-(1,2,4)-oxadiazinan-5-one and their use as anti-antherosclerotic agents
AU2002323481A1 (en)	2003-03-18	Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents